This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Flush with new business, Philadelphia-based CDMO PCI Pharma Services is blueprinting multiple manufacturing outlays on both sides of the Atlantic. | Altogether, PCI’s manufacturing projects represent an investment of more than $365 million.
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drugdelivery and drug-device combination product assembly in Rockford, Illinois.
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. An example is the ability of a patient suffering from venous thrombosis to perform their own injections of heparin – an anticoagulant often packaged in a prefilled syringe.
Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drugdelivery methods across patient groups.
As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drugdelivery and prefilled syringe market in the coming years. The injectable drugdelivery market is expected to rise at a compound annual growth rate of 12.9%
Workshop will be on ‘Ophthalmic DrugDelivery Development – Trials and Tribulations’. Ophthalmic DrugDelivery is compelling for many reasons, including the major issue of patient compliance and tolerability of therapies. Ophthalmic Drugs Conference. Hosted by Brian Levy, CEO, Ocunexus Therapeutics.
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
SHL Medical is a world-leading solutions provider for advanced drugdelivery systems with a unified purpose to further enable patient independence. Currently, SHL Medical has four locations, in Switzerland, Taiwan, Sweden, and the US, with Taiwan being the main manufacturing location.
” XTALKS WEBINAR: DrugDelivery — Addressing Global Regulatory Challenges in Co-Packaged, On-Body Systems Live and On-Demand: Thursday, June 15, 2023, at 10am EDT (4pm CEST/EU-Central) Register for this free webinar to learn about the differences and similarities between the US and EU regulatory frameworks for co-packaged combination products.
The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. The patch itself is made of biodegradable nanocellulose and contains no plastic additives. Behfar, senior scientist at VTT, in the news release.
Organizers of the drugdelivery and packaging event have shared an industry report that reveals what is likely to push innovation forward in the future.
Sustainability for Injectable Delivery Devices. Primary Packaging Development. Connected DrugDelivery Devices. Delve into the considerations for material components for the development of primary packaging. Kevin Kusmierek, Scientist, Primary Packaging and Medical Devices, CSL Behring.
In earlier times, container closure integrity testing was not regarded as an essential step in the process of manufacturing. The company developing drug product through such an intense process, use to consider container closure system only for packaging of the product. [1] Container Closure Integrity Testing Services Market.
Driven by the increasing need for safe and efficient medical devices and drugdelivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. Presently, polymers are employed in various fields, including agricultural, aircraft, automotive, consumer science, medicine, packaging, and sports.
Medical devices such as drug-delivering systems and body implants as well as temperature-sensitive devices can be sterilized efficiently by vaporizing hydrogen peroxide using low temperature and deep vacuum conditions. The cycle time relies on factors like load size, packaging materials and composition of the medical device.
They offer several advantages over traditional drugdelivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. Prefilled syringes are syringes that come pre-filled with a specific dose of medication.
The demand for injectable drugs is rising. According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. The injectable drugs market is currently valued at around $532 billion.
While the industry is seeing advances in alternative drugdelivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry. Tablet manufacturing, which is the most common OSD form, takes an API dry powder ingredient and compresses it to form tablets, which can be coated or uncoated.
Startup sets out to tackle the gene therapy manufacturing crisis ( Endpoints ).
Esker, a new biotech startup, launches with plans to make targeted immune drugs ( BioPharma Dive ).
Microneedles are promising devices for painless drugdelivery with minimal side effects ( EurekAlert ).
PBMs serve as intermediaries between insurers, pharmacies and drugmanufacturers, negotiating discounts and managing drug formularies. While PBMs were originally intended to lower costs and streamline drugdelivery, critics argue that their practices often lead to inflated prices and restricted access for consumers.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content